SOD1 and Platelet storage pool disease: Concordantly, here we demonstrated that AntiOxCIN4 treatment of fibroblasts from sPD patients decreased ROS levels and cellular stress response, while metabolic activity, redox state and total SOD activity were increased, maximal respiration was restored, and mitochondrial swelling was decreased.